Back to top

Impax Laboratories Inc: (NASD: IPXL)

(U.S: NASD) As of Apr 24, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$26.71 USD

+0.44 (1.68%)

Volume: 971,219

Zacks Rank : 2-Buy [?]   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Quote Overview

Stock Activity

Open 26.45
Day Low 25.84
Day High 26.83
52 Wk Low 16.09
52 Wk High 28.50
Avg. Volume 808,524
Market Cap 1.83 B
Dividend 0.00 ( 0.00%)
Beta 1.00

Key Earnings Data

Forward PE 35.62
PEG Ratio 1.57
Current Qtr Est 0.12
Current Yr Est 0.73
Most Accurate Est 0.10
Qtr Earnings ESP[?] -16.67%
Exp Earnings Date *AMC5/1/2014
Prior Year EPS 0.83
Exp EPS Growth 22.63%
Industry MED-GENERIC DRG

Earnings ESP (Expected Surprise Prediction) is Zacks’ proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement.

Read more about this innovative method in the Zacks Earnings ESP Guide See all the top Earnings ESP Stocks.

Premium Research for IPXL

Zacks Rank [?] Rank Change Trend Buy 2
Zacks Industry Rank 10 / 265 (Top 4%)
Equity Research Report

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn more about the Zacks Rank

Zacks Rank Home - All Zacks Rank resources in one place

Zacks Premium - The only way to get access to the Zacks Rank

( = Change in last 30 days)

View All Zacks Rank #1 Strong Buys

Learn to Profit from the Zacks Rank

Zacks Recommendation has been removed. Learn more

Due to overwhelming customer feedback we have removed the Zacks Recommendation. Unfortunately, having two separate rating systems proved far too confusing to most investors. Going forward we will just focus on the Zacks Rank which has a longer and more impressive track record of outperformance. Even though the Zacks Rank is primarily used for stock trading in a 1-3 month time frame, it also can be very helpful for long term investors. To learn more about using the Zacks Rank for long term investing, click here.

Premium Research : Industry Analysis

Top Peers Symbol Zacks Rank
IMPAX LABORATRS IPXL
MALLINCKRODT PL MNK
ACTAVIS PLC ACT
DOCTOR REDDYS RDY
KALOBIOS PHARMA KBIO
MYLAN INC MYL
TEVA PHARM ADR TEVA
AKORN INC AKRX
AQUINOX PHARMA AQXP
AXOGEN CORP AXGN

See all MED-GENERIC DRG Peers>>